Even though Acceleron sold itself to Merck for $180 per share last month, the company evaluated other options before pulling the trigger. One of those options was seeing whether Bristol Myers Squibb ...
Hoffman Estates, IL, USA; March 19, 2013 -- JCL Bioassay USA, a Leading Japanese CRO specialized in Bioassay services utilizing ultra sensitive and proprietary methodologies, has announced a ...
Merck & Co. can count one more investment firm as an opponent of its planned $11.5 billion takeover of Acceleron Pharma. Farallon Capital Management, which owns more than a 4% stake in Acceleron, said ...
Reports emerged late Wednesday afternoon that Merck emerged as the winning suitor with a deal valued at about $11 billion. The question of which pharma giant will acquire rare disease-focused ...
Asus has announced the refreshed lineup of Chromebook CX14 and Chromebook CX15 series laptops, powered by Intel Celeron processors. As per the company, both models are available in 14-inch and 15-inch ...
TL;DR: Intel has discontinued its RS1 stock cooler, which was bundled with the entry-level Pentium G7400 and Celeron G6900 processors. The RS1 will not have a direct successor, instead the existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback